To access all features of this site, you must enable Javascript. Here are the instructions for enabling Javascript in your web browser.
To carry out their activities, Research Teams of the Frédéric Joliot Institute for Life Sciences have developed high-profile technological platforms in many areas : biomedical imaging, structural biology, metabolomics, High-Throughput screening, level 3 microbiological safety laboratory...
All the news of the Institute of life sciences Frédéric Joliot
En collaboration avec Sanofi et un laboratoire espagnol, des chercheurs du SCBM ont mis au point un nanocatalyseur au ruthénium permettant d’incorporer du deutérium ou du tritium avec un grande efficacité et précision dans des molécules polaires complexes et des biomédicaments en milieu aqueux.
Des chercheurs du DMTS en collaboration avec l’Institut Pasteur, ont découvert et caractérisé une nouvelle toxine, l’ingrilimine, produite par un micro-organisme du phytoplancton. Ses propriétés singulières vis-à-vis d’un récepteur clé de processus neurodégénératifs et cancéreux ouvrent la voie à la conception de nouvelles stratégies thérapeutiques.
Inspired by a metalloenzyme that reduces CO₂ to CO, researchers from I2BC designed two variants of an iron-porphyrin-based catalyst that differ only in the spatial arrangement of the reactive groups in the second coordination sphere. One of these configurations achieves remarkable catalytic performance.
A team from SIMoS, in collaboration with a team from I2BC, has validated a quantitative bacterial two-hybrid system that they developed for the high-throughput analysis of protein–protein interactions (PPIs). This approach enables the quantitative analysis of PPIs based on data suitable for training AI models.
Researchers from NeuroSpin have published the first functional magnetic resonance imaging (fMRI) scans acquired using NeuroSpin’s ISEULT 11.7 Tesla MRI scanner, while exploring the challenges of this ultra-high-field MRI modality.
Researchers from I2BC, the University of Leicester, IPBS, and ISS have resolved the structure and identified specific contacts mediating interactions within a complex consisting of the Ku70/Ku80 heterodimer, DNA, and the exonuclease domain of the WRN protein, whose dysfunction is responsible for a rare disease associated with a high risk of cancer.
Using complementary imaging methods, researchers from NeuroSpin and the Vision Institute show that the propagation of action potentials in the myelinated axons of rodent optic nerves does not trigger neurovascular coupling.
The CEA is revealing a series of in vivo human brain images acquired with the Iseult MRI machine and its unmatched 11.7 teslas magnetic field strength. This success is the fruit of more than 20 years of R&D as part of the Iseult project, with one pillar goal being to design and build the world’s most powerful MRI machine. Its ambition is to study healthy and diseased human brains with an unprecedented resolution, allowing us to discover new details relating to the brain’s anatomy, connections, and activity.
In an article in the New York Times, Stanislas Dehaene (NeuroSpin director) and Mathias Sablé-Meyer (PhD student) discuss recent results obtained in collaboration with the Collège de France, the CNRS and the University of Paris 8 that show that humans have a universal capacity to understand abstract geometric concepts.
September 2021, the 11.7 Tesla MRI of the Iseult project, the most powerful in the world for human imaging, has just unveiled its first images.
Le projet EXPERIENCE cherche à utiliser la réalité virtuelle pour améliorer la vie quotidienne en permettant de nouvelles formes d’interaction sociale et d’expression personnelle.
CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.
